naltrexone has been researched along with Psychotic Disorders in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuan-Ya, L; Ruei-Yuan, H | 1 |
| Howland, RH | 1 |
| Guloksuz, S; Reutenauer, EL; Srihari, VH; Tek, C | 1 |
| Borsook, D; Elman, I; Langleben, DD; Simonson, DC; Swift, R; Taveira, TH; Tschibelu, E; Wu, WC; Yamamoto, R | 1 |
| Ganguli, R; O'Malley, SS; Ratliff, J; Reutenauer, E; Tek, C | 1 |
| Banga, A; Connor, DF | 1 |
| Carroll, K; Levinson, C; Nich, C; Petrakis, I; Poling, J; Ralevski, E; Rounsaville, B | 1 |
| Volavka, J | 1 |
| Buchsbaum, MS; Davis, GC | 1 |
| Agman, G; Godart, NT; Jeammet, P; Perdereau, F | 1 |
5 trial(s) available for naltrexone and Psychotic Disorders
| Article | Year |
|---|---|
Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Clinical Protocols; Double-Blind Method; Female; Humans; Male; Mental Disorders; Middle Aged; Naltrexone; Narcotic Antagonists; Overweight; Psychotic Disorders; Research Design; Schizophrenia; Weight Gain; Weight Loss | 2013 |
The effect of naltrexone on body fat mass in olanzapine-treated schizophrenic or schizoaffective patients: a randomized double-blind placebo-controlled pilot study.
Topics: Adipose Tissue; Adult; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Double-Blind Method; Female; Humans; Insulin Resistance; Lipids; Liver Function Tests; Male; Middle Aged; Naltrexone; Olanzapine; Pilot Projects; Psychotic Disorders; Schizophrenia; Young Adult | 2014 |
A randomized, double-blind, placebo-controlled pilot study of naltrexone to counteract antipsychotic-associated weight gain: proof of concept.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cholesterol; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Pilot Projects; Psychotic Disorders; Quality of Life; Schizophrenia; Triglycerides; Weight Gain; Young Adult | 2014 |
Naltrexone and disulfiram in patients with alcohol dependence and current depression.
Topics: Alcohol Deterrents; Alcoholism; Bipolar Disorder; Cocaine-Related Disorders; Comorbidity; Connecticut; Depressive Disorder, Major; Disulfiram; Double-Blind Method; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Gastrointestinal Diseases; Humans; Male; Massachusetts; Middle Aged; Naltrexone; Narcotic Antagonists; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Stress Disorders, Post-Traumatic; Treatment Outcome; Veterans | 2007 |
Action of naloxone and naltrexone in different types of psychoses.
Topics: Bipolar Disorder; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Endorphins; Humans; Naloxone; Naltrexone; Psychotic Disorders; Receptors, Opioid; Schizophrenia | 1981 |
5 other study(ies) available for naltrexone and Psychotic Disorders
| Article | Year |
|---|---|
Naltrexone-induced psychosis in a patient with alcohol use disorder.
Topics: Alcohol Drinking; Alcoholism; Double-Blind Method; Humans; Naltrexone; Psychotic Disorders | 2023 |
Therapies for obesity and medication-associated weight gain.
Topics: Animals; Appetite Depressants; Bariatric Surgery; Benzazepines; Bupropion; Chronic Disease; Combined Modality Therapy; Diet, Reducing; Disease Models, Animal; Drug Combinations; Exercise; Fructose; Humans; Mood Disorders; Naltrexone; Obesity; Overweight; Phentermine; Psychotic Disorders; Randomized Controlled Trials as Topic | 2013 |
Effectiveness of naltrexone for treating pathologic skin picking behavior in an adolescent with Prader-Willi syndrome.
Topics: Adolescent; Antipsychotic Agents; Behavior Therapy; Compulsive Behavior; Humans; Intellectual Disability; Male; Naltrexone; Narcotic Antagonists; Prader-Willi Syndrome; Psychotic Disorders; Risperidone | 2012 |
Pain sensitivity and endorphins in functional psychoses.
Topics: Bipolar Disorder; Depressive Disorder; Endorphins; Evoked Potentials, Somatosensory; Female; Humans; Male; Naltrexone; Nociceptors; Pain; Psychotic Disorders; Receptors, Opioid; Schizophrenic Psychology; Sensory Thresholds | 1981 |
Naltrexone treatment of self-injurious behavior.
Topics: Adolescent; Drug Therapy, Combination; Eye Injuries; Humans; Male; Mood Disorders; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Psychotic Disorders; Psychotropic Drugs; Self-Injurious Behavior; Treatment Outcome | 2000 |